Tag - medicine

 
 

MEDICINE

Japan Times
JAPAN / Science & Health
Dec 10, 2021
Japan researchers use ostrich cells to make glowing COVID-19 detection masks
The discovery could help advance low-cost, at-home testing, and may potentially help those suffering from allergies and other ailments.
Japan Times
COMMENTARY / World
Dec 8, 2021
How the U.S. can rein in skyrocketing drug prices
Negotiated prices on many medications would introduce an important new form of cost control in uncompetitive corners of the U.S. prescription-drug market.
Japan Times
WORLD / Science & Health
Dec 7, 2021
New COVID-19 pills offer hope as omicron looms
Two new antiviral pills are coming soon, and are expected to work against all versions of the virus.
Japan Times
COMMENTARY / World
Dec 5, 2021
Who’s afraid of evidence-based policymaking?
As societies struggle to reopen in the shadow of new COVID-19 variants, social experiments are urgently needed to ensure that we implement policies with proven records of success.
Japan Times
WORLD / Science & Health
Dec 3, 2021
Six vaccines show promise as boosters, led by mRNA shots
Researchers tested the vaccines in more than 2,800 volunteers 30 and older who had already received two doses of the AstraZeneca or Pfizer shots.
Japan Times
EDITORIALS
Dec 3, 2021
Omicron is a wake-up call to fix vaccine inequality
The most important factor in COVID-19's evolution and the threat its variants pose is the size of unvaccinated populations and the reservoirs in which they can develop.
Japan Times
JAPAN / FOCUS
Dec 2, 2021
Japan’s drug regulator considers sweeping changes after COVID-19 vaccine delay
After being one of the last major developed nations to approve Pfizer's vaccine, Japan's drug regulator is looking to ease approval requirements for future pandemics.
Japan Times
COMMENTARY / World
Dec 1, 2021
What’s worst about omicron so far is the uncertainty
How should the world respond to omicron? We just have to wait as there is information that we don't yet have. And for many, the waiting itself is the problem.
Japan Times
COMMENTARY / World
Nov 30, 2021
Omicron is the price we pay for vaccine inequality
Amsterdam's main airport went into lockdown recently after 61 passengers on two flights from southern Africa tested positive for the new virus. Japan, Hong Kong and Israel have also reported cases.
Japan Times
COMMENTARY / World
Nov 29, 2021
COVID-19 has changed socialized medicine in Britain forever
How did the U.K. make it through the past 20 months of COVID-19? The private sector's role in delivering publicly funded care needs to be acknowledged.
Japan Times
WORLD / Science & Health
Nov 28, 2021
Moderna says new vaccine for omicron may be ready in early 2022
Moderna's chief medical officer says the company should know about the ability of the current vaccine to provide protection in the next couple of weeks.
Japan Times
COMMENTARY / World
Nov 28, 2021
Can vaccines get rid of long COVID?
The subject of long COVID has also been divisive, with social media full of both support groups and skeptics.
Japan Times
WORLD
Nov 27, 2021
Merck says its antiviral pill is less effective in final analysis
A final analysis of a clinical trial said the antiviral pill reduced the risk of hospitalization and death among high-risk COVID patients by 30%, down from an earlier estimate of 50%.
Japan Times
COMMENTARY / World
Nov 26, 2021
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It's suggested that Britain's home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Japan Times
COMMENTARY / World
Nov 24, 2021
Mass COVID-19 testing: Does it save lives?
Would Japan have seen far greater fatalities if it opted for mass COVID-19 testing like other countries rather than just targeting vulnerable group as it did?
Japan Times
WORLD / Science & Health
Nov 16, 2021
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.
Japan Times
JAPAN
Nov 13, 2021
COVID cases in Tokyo hit 471,000 as of March — quadruple official tally — study says
Researchers say asymptomatic or mild cases likely behind dramatic undercount in number of coronavirus infections.
Japan Times
COMMENTARY / World
Nov 12, 2021
Why COVID-19 misinformation works
Misinformed people, especially about COVID-19, do not simply have inaccurate information; they are heavily invested in their misconceptions.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?